Gel Column Agglutination Test System Market

The anti-human globulin column agglutination technology test eliminates the need to wash red cells, reducing overall test time. The test is simple to carry out, and the results are more objective than those obtained using tube and microplate methods. In addition, antibodies and other proteins in biological samples are detected using these systems.

The key drivers of the gel column agglutination test system market are the rise in applications in industries like pharmaceuticals, biologics, agrichemicals, food additives, and others, the increase in spending on research and development, the rise in the number of end users, and the improvements in performance that come with newer versions of gel column agglutination tests.

High manufacturing costs, difficulty predicting future customer requirements, lack of standardization among different manufacturers, product fragmentation, and an increase in new product launches are some of the critical challenges faced by players in the global gel column agglutination test system market.

This market is growing because the pharmaceutical and biotechnology industries need more reliable testing methods, manufacturing processes need more quality control, and R&D spending is going up.
The assay-based gel column agglutination test system segment will account for most of the overall market in 2018. However, this segment's industrial applications will come in second, then the clinical and veterinary diagnostics needs.

With a revenue share of more than **% in 2018, North America will dominate the global gel column agglutination test system market. This region is expected to overgrow as people become more aware of health-related issues such as pandemics and food safety. Due to their vital healthcare sectors, European countries are expected to see growth rates during the forecast period. 

However, because of rising incidences of acute diseases such as cancer, which necessitate accurate diagnosis, Asia-Pacific is expected to grow faster than other regions. In addition, increased medical research and development investments are expected to drive significant growth in Latin America and the Middle East over the next five years.

Bio-Rad Laboratories, Thermo Fisher Scientific, Beckman Coulter, and Shimadzu Corporation are some key players in the gel column agglutination test system market.